Methemoglobinemia laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 22: Line 22:
Most common cause include different oxidant drugs, toxins or chemicals
Most common cause include different oxidant drugs, toxins or chemicals


==Laboratory Findings==
==Laboratory Findings==    
<ref>{{ Rev Bras Anestesiol. 2008 Nov-Dec;58(6):651-64. Methemoglobinemia: from diagnosis to treatment. [Article in English, Portuguese] do Nascimento TS1, Pereira RO, de Mello HL, Costa J.pmid=PMID: 19082413}}</ref>  <ref>{{ Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:4570-4573. doi: 10.1109/EMBC.2017.8037873.
Three-wavelength method for the optical differentiation of methemoglobin and sulfhemoglobin in oxygenated blood.
Van Leeuwen SR, Baranoski GVG, Kimmel BW. pmid=29060914 }}</ref>      <ref>{{Toxicol Rev. 2003;22(1):13-27.
Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue.
Bradberry SM1. pmid=14579544}}</ref>    <ref>{{South Med J. 2011 Nov;104(11):757-61. doi: 10.1097/SMJ.0b013e318232139f.
Methemoglobinemia: pathogenesis, diagnosis, and management.
Skold A1, Cosco DL, Klein R. pmid=22024786 }}</ref>
 


'''ABG Analysis'''
'''ABG Analysis'''
Line 39: Line 47:


In methemoglobinemia patients we often see the so called “saturation gap” which can help us diagnose the condition. The gap is calculated by the difference between the Oxygen value from the ABG analysis (typically normal in methemoglobinemia patients 100%) and the pulse ox -oxygen saturation (always ~85% in methemoglobiemia patients). Saturaion gap more than 5 % is significant.
In methemoglobinemia patients we often see the so called “saturation gap” which can help us diagnose the condition. The gap is calculated by the difference between the Oxygen value from the ABG analysis (typically normal in methemoglobinemia patients 100%) and the pulse ox -oxygen saturation (always ~85% in methemoglobiemia patients). Saturaion gap more than 5 % is significant.
{{Reflist|2}}


==References==
==References==

Revision as of 00:27, 30 April 2018

Methemoglobinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Methemoglobinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Methemoglobinemia laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Methemoglobinemia laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Methemoglobinemia laboratory findings

on Methemoglobinemia laboratory findings

Methemoglobinemia laboratory findings in the news

Blogs on Methemoglobinemia laboratory findings

Directions to Hospitals Treating Methemoglobinemia

Risk calculators and risk factors for Methemoglobinemia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Congenital (Hereditary) Methemoglobinemia

There are three main congenital conditions that lead to methemoglobinemia:

1. Cytochrome b5 reductase deficiency and pyruvate kinase deficiency

2. G6PD deficiency

3. Presence of abnormal hemoglobin.


Acquired or Acute Methemoglobinemia

Most common cause include different oxidant drugs, toxins or chemicals

Laboratory Findings

[1] [2] [3] [4]


ABG Analysis

On routine ABG analysis the partial pressure of oxygen (PO2) value should in normal reference ranges in patients with methemoglobinemia. The reason lies in the fact that the ABG value represents the oxygen content in the plasma, and not the oxygen-carrying capacity of hemoglobin.

Co-oximetry

The co-oximeter is the most accurate device to measure methemoglobin. The newer generation devices can actually differentiate between methemoglobin, carboxyhemoglobin, oxyhemoglobin, deoxyhemoglobin, and also Sulfhemoglobin.

Pulse oximetry

The pulse oximetry in methemoglobinemia patients will always show a value around 85%, regardless of the level of MetHb in the blood. This is very importan tot know as this value can be misleading especially in patients with very high MetHb levels Fortunately new multiwavelength pulse oximeters have been developed recently and they can detect the levels of MetHb more accurately.

In methemoglobinemia patients we often see the so called “saturation gap” which can help us diagnose the condition. The gap is calculated by the difference between the Oxygen value from the ABG analysis (typically normal in methemoglobinemia patients 100%) and the pulse ox -oxygen saturation (always ~85% in methemoglobiemia patients). Saturaion gap more than 5 % is significant.

  1. {{ Rev Bras Anestesiol. 2008 Nov-Dec;58(6):651-64. Methemoglobinemia: from diagnosis to treatment. [Article in English, Portuguese] do Nascimento TS1, Pereira RO, de Mello HL, Costa J.pmid=PMID: 19082413}}
  2. {{ Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:4570-4573. doi: 10.1109/EMBC.2017.8037873. Three-wavelength method for the optical differentiation of methemoglobin and sulfhemoglobin in oxygenated blood. Van Leeuwen SR, Baranoski GVG, Kimmel BW. pmid=29060914 }}
  3. {{Toxicol Rev. 2003;22(1):13-27. Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue. Bradberry SM1. pmid=14579544}}
  4. {{South Med J. 2011 Nov;104(11):757-61. doi: 10.1097/SMJ.0b013e318232139f. Methemoglobinemia: pathogenesis, diagnosis, and management. Skold A1, Cosco DL, Klein R. pmid=22024786 }}

References

Template:WS Template:WH